Mainland-based Clover Biopharmaceuticals has started pitching investors for its up to HK$2.03bn ($260.5m) IPO, opening bookbuilding in Hong Kong on Monday. The company, which is developing a Covid-19 …
( read original story …)
The HongKong News
Mainland-based Clover Biopharmaceuticals has started pitching investors for its up to HK$2.03bn ($260.5m) IPO, opening bookbuilding in Hong Kong on Monday. The company, which is developing a Covid-19 …
( read original story …)